SRF231, a fully human CD47 antibody, potentiates the effects of opsonizing antibodies and cytotoxic chemotherapies in preclinical cancer models
- Resource Type
- Journal
- Source
CANCER RESEARCH ; AUG 2020, 80 16, 2p. Supplement: S- Subject
- Language
- English
- ISSN
- 15387445